Ask the Experts: Clinical Case Studies Focusing on Non-statin Therapies for Treating Patients with Hypercholesterolemia
Registration closed - On-demand version of this activity coming in May.
Available at least 24 hours before webinar.
Activity Type: Application-based
CE Credits: 1.0
Activity Fee: Free of Charge
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Methods and CE Requirements
This is a live broadcast consisting of audio, presentation slides, and an activity evaluation tool. A live webinar brings the presentation to you. Listen to the speaker present in “real time” as you watch the slides on the screen. You will have the opportunity to ask the speaker questions at the end of the program. Please join the conference at least 5 minutes before the scheduled start time for important announcements.
To receive CE credit, participants must submit an enrollment code (announced during the webinar) and complete the evaluation. Participants will process CE credit online at ASHP's eLearning portal, CPE credit will be reported directly to CPE Monitor. Per ACPE, CPE credit must be claimed no later than 60 days from the date of the live activity or completion of a home study activity.
Target Audience
This continuing education activity was planned to meet the needs of pharmacists in a variety of practice settings, including large and small healthcare settings, ambulatory care clinics, managed care organizations, and academia. The activity is particularly beneficial for pharmacists, clinical specialists, managers, leaders, and educators who care for patients with hypercholesterolemia.
Activity Overview
This activity will focus on current issues related to the use of non-statin therapies for treating patients with hypercholesterolemia. The faculty will address the key issues and provide practice pearls for pharmacists.
The content for this activity is based on questions and comments from participants at a recent educational symposium on this topic. Time for additional questions from the webinar audience will be provided at the end of the presentation.
Learning Objectives
After the conclusion of this application-based educational activity, participants should be able to- Describe the evidence evaluating reduction in cardiovascular events with statin and non-statin combination therapy.
- Evaluate the use of non-statin therapies for the treatment of hypercholesterolemia in patients who cannot achieve desired LDL-C.
- Evaluate the use of non-statin therapies for the treatment of hypercholesterolemia in patients who report statin related muscle symptoms.
Faculty
Joseph Saseen, Pharm.D., BCPS, BCACP, FASHP, FCCP Activity Chair
Professor, Departments of Clinical Pharmacy and Family Medicine
Vice-Chair, Department of Clinical Pharmacy
University of Colorado School of Pharmacy
Aurora, Colorado
Joseph Saseen, Pharm.D., is Professor of Clinical Pharmacy and Family Medicine, and Vice-Chair of the Department of Clinical Pharmacy at the University of Colorado. He is Clinical Pharmacy Specialist in family medicine, Director of the PGY2 Ambulatory Care residency program and is a Board Certified Pharmacotherapy Specialist (BCPS) and Board Certified Ambulatory Care Pharmacist (BCACP).
Dr. Saseen received his Bachelor of Science degree in pharmacy and his Doctor of Pharmacy degree from the University at Buffalo. He completed a fellowship in ambulatory care research at the University of Colorado Health Sciences Center.
At the University of Colorado, Dr. Saseen participates in research related to the pharmacotherapy of chronic diseases (e.g., hypertension, dyslipidemia) and program grants related to the expansion of ambulatory care clinical services.
Dr. Saseen is a Fellow of the American Society of Health-System Pharmacists, American College of Clinical Pharmacy, and National Lipid Association. He is a past member and Chair of the Board of Pharmacy Specialties and is a board member of the National Lipid Association. He has several publications related to the pharmacotherapy of cardiovascular and was recipient of the American College of Clinical Pharmacy 2014 Education Award and the American Associations of Colleges of Pharmacy 2016 Teaching Innovations.
Kim K. Birtcher, Pharm.D, M.S., BCPS-AQ Cardiology, CLS, CDE, AACC, FNLA
Professor
University of Houston College of Pharmacy
Clinical Pharmacist
Kelsey-Seybold Clinic
Houston, Texas
Kim K. Birtcher, Pharm.D. is Clinical Professor at the University of Houston College of Pharmacy and clinical pharmacist at the Kelsey-Seybold Cardiology Clinic in Houston.
Dr. Birtcher received her Bachelor of Science degree in pharmacy and Master of Science degree in pharmacy administration from the University of Texas at Austin. She received her Doctor of Pharmacy degree from the University of Florida.
As a clinical pharmacist at the Kelsey-Seybold Cardiology Clinic in Houston, Texas, she is responsible for treating patients at the Secondary Prevention Lipid Clinic. Her teaching and research interests are in cardiovascular risk reduction and quality improvement initiatives.
Dr. Birtcher is a board certified pharmacotherapy specialist with additional qualifications in cardiology, a certified diabetes educator, and a clinical lipid specialist. She is an Associate of the American College of Cardiology (AACC) and a fellow of the National Lipid Association (FNLA). Dr. Birtcher is active in the American College of Cardiology (ACC), serving as the Co-Chair for the Cardiovascular Team Section’s Working Group for Clinical Pharmacists. She is a member of the ACC/AHA Task Force on Clinical Practice Guidelines and the past Co-Chair of the LDL: Address the Risk Initiative launched by the ACC.
Viewing Webinar as a Group
To view the webinar as a group, one person serving as the group coordinator should register. A few minutes before the webinar begins, the group coordinator should launch the webinar (using instructions from the email confirmation) and select the option to open audio via VoIP (Voice Over IP) or use a touch tone phone with the dial-in information. Each participant will process their own continuing education online.
Webinar System Requirements
Be sure to view the webinar system requirements for Windows, Mac, iOS, and Android prior to the activity.
Ask the Experts: Clinical Case Studies Focusing on Non-statin Therapies for Treating Patients with Hypercholesterolemia
Activity Overview
This activity will focus on current issues related to the use of non-statin therapies for treating patients with hypercholesterolemia. The faculty will address the key issues and provide practice pearls for pharmacists.
The content for this activity is based on questions and comments from participants at a recent educational symposium on this topic. Time for additional questions from the webinar audience will be provided at the end of the presentation.
Release Date: Monday, May 15, 2017
Expiration Date: Monday, May 15, 2018
Activity Type: Application-based
CE Credits: 1.0
Activity Fee: Free of Charge
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Target Audience
This continuing education activity was planned to meet the needs of pharmacists in a variety of practice settings, including large and small healthcare settings, ambulatory care clinics, managed care organizations, and academia. The activity is particularly beneficial for pharmacists, clinical specialists, managers, leaders, and educators who care for patients with hypercholesterolemia.
Activity Overview
This activity will focus on current issues related to the use of non-statin therapies for treating patients with hypercholesterolemia. The faculty will address the key issues and provide practice pearls for pharmacists.
The content for this activity is based on questions and comments from participants at a recent educational symposium on this topic. Time for additional questions from the webinar audience will be provided at the end of the presentation.
Learning Objectives
After the conclusion of this knowledge-based educational activity, participants should be able to- Describe the evidence evaluating reduction in cardiovascular events with statin and non-statin combination therapy.
- Evaluate the use of non-statin therapies for the treatment of hypercholesterolemia in patients who cannot achieve desired LDL-C.
- Evaluate the use of non-statin therapies for the treatment of hypercholesterolemia in patients who report statin related muscle symptoms.
Faculty
Joseph Saseen, Pharm.D., BCPS, BCACP, FASHP, FCCP Activity Chair
Professor, Departments of Clinical Pharmacy and Family Medicine
Vice-Chair, Department of Clinical Pharmacy
University of Colorado School of Pharmacy
Aurora, Colorado
Joseph Saseen, Pharm.D., is Professor of Clinical Pharmacy and Family Medicine, and Vice-Chair of the Department of Clinical Pharmacy at the University of Colorado. He is Clinical Pharmacy Specialist in family medicine, Director of the PGY2 Ambulatory Care residency program and is a Board Certified Pharmacotherapy Specialist (BCPS) and Board Certified Ambulatory Care Pharmacist (BCACP).
Dr. Saseen received his Bachelor of Science degree in pharmacy and his Doctor of Pharmacy degree from the University at Buffalo. He completed a fellowship in ambulatory care research at the University of Colorado Health Sciences Center.
At the University of Colorado, Dr. Saseen participates in research related to the pharmacotherapy of chronic diseases (e.g., hypertension, dyslipidemia) and program grants related to the expansion of ambulatory care clinical services.
Dr. Saseen is a Fellow of the American Society of Health-System Pharmacists, American College of Clinical Pharmacy, and National Lipid Association. He is a past member and Chair of the Board of Pharmacy Specialties and is a board member of the National Lipid Association. He has several publications related to the pharmacotherapy of cardiovascular and was recipient of the American College of Clinical Pharmacy 2014 Education Award and the American Associations of Colleges of Pharmacy 2016 Teaching Innovations.
Kim K. Birtcher, Pharm.D, M.S., BCPS-AQ Cardiology, CLS, CDE, AACC, FNLA
Professor
University of Houston College of Pharmacy
Clinical Pharmacist
Kelsey-Seybold Clinic
Houston, Texas
Kim K. Birtcher, Pharm.D. is Clinical Professor at the University of Houston College of Pharmacy and clinical pharmacist at the Kelsey-Seybold Cardiology Clinic in Houston.
Dr. Birtcher received her Bachelor of Science degree in pharmacy and Master of Science degree in pharmacy administration from the University of Texas at Austin. She received her Doctor of Pharmacy degree from the University of Florida.
As a clinical pharmacist at the Kelsey-Seybold Cardiology Clinic in Houston, Texas, she is responsible for treating patients at the Secondary Prevention Lipid Clinic. Her teaching and research interests are in cardiovascular risk reduction and quality improvement initiatives.
Dr. Birtcher is a board certified pharmacotherapy specialist with additional qualifications in cardiology, a certified diabetes educator, and a clinical lipid specialist. She is an Associate of the American College of Cardiology (AACC) and a fellow of the National Lipid Association (FNLA). Dr. Birtcher is active in the American College of Cardiology (ACC), serving as the Co-Chair for the Cardiovascular Team Section’s Working Group for Clinical Pharmacists. She is a member of the ACC/AHA Task Force on Clinical Practice Guidelines and the past Co-Chair of the LDL: Address the Risk Initiative launched by the ACC.
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.
All faculty and planners for ASHP Advantage education activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests. ASHP Advantage identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.
- Faculty and planners report no financial relationships relevant to this activity.
Methods and CE Requirements
This is an online activity consisting of audio and slides, an assessment, and a course evaluation. Participants should claim CE credit for this home-study educational activity only if they have not claimed credit for the live activity. Participants must view the entire presentation, take a pretest and posttest, and complete the course evaluation to receive CE credit.
To access the activity, click "Launch Presentation" below. On the last slide of the presentation you must click the “Close Activity and Process CE” button to link to ASHP’s elearning portal to complete the process for obtaining credit. Per ACPE, CPE credit must be claimed no later than 60 days from the date of the live activity or completion of a home-study activity. CPE credit will be reported directly to CPE Monitor.
